This Form 4 filing reports director Carolyn Downey's transactions involving phantom stock conversion at Armour Residential REIT, Inc. (ARR). On May 21, 2026, Downey converted 1,900 shares of vested phantom stock into common stock and cash. Specifically, 950 shares were converted into 950 shares of ARMOUR common stock, ...

This filing details transactions made by ULM SCOTT, CEO of Armour Residential REIT, Inc. (ARR), on May 21, 2026. Scott Ulm converted 2,028 vested phantom stock units into 2,028 shares of common stock. Additionally, 1,352 vested phantom stock units were converted into cash to cover income taxes. These transactions are p...

On May 21, 2026, Armour Residential REIT CFO Gordon Harper converted 4,000 shares of vested phantom stock. Of these, 2,679 shares were converted into common stock of ARMOUR (ARR), while the remaining 1,321 shares were converted to cash at $16.47 per share solely to cover income taxes on the vested stock. The conversion...

This filing details transactions by Desmond Macauley, Co-Chief Investment Officer of Armour Residential REIT, Inc. On May 21, 2026, Macauley converted 1,111 vested phantom stock units into 1,111 shares of common stock. Additionally, 389 vested phantom stock units were converted into cash to cover income taxes. These tr...

On May 21, 2026, Sergey Losyev, Co-Chief Investment Officer of Armour Residential REIT, Inc., engaged in several transactions. Losyev converted 1,219 vested phantom stock units into 1,219 shares of the company's common stock. Additionally, 281 vested phantom stock units were converted into cash to cover income taxes. T...

This Form 4 filing reports that Lefebvre d'Ovidio Manfredi, a director of Arqit Quantum Inc. (ARQQ), sold Business Combination Warrants on May 21-22, 2026. On May 21, he sold 787 warrants at $2.10 per warrant, reducing his position to 23,304.80 equivalent ordinary shares. On May 22, he sold an additional 1,001 warrants...

Director Forrest Reynolds T. filed a Form 4 disclosing the conversion of 61 shares of Series 1C Convertible Preferred Stock into 28,343 shares of common stock of Ascent Solar Technologies, Inc. (ASTI) on May 22, 2026. The conversion was executed at the predetermined price of $2.50 per common share, resulting in Reynold...

This Form 4 filing details a transaction by Gena L. Ashe, Chief Legal Officer & Corp Sec of Anterix Inc. On May 22, 2026, 2501 shares of Common Stock were disposed of with a price of $60.0 per share. This disposal was to satisfy withholding obligations in connection with the partial vesting and settlement of restricted...

Philip Mazzara, General Counsel and Secretary of Astera Labs, Inc., sold 796 shares of common stock on May 21, 2026, at a price of $291.0251 per share. This transaction was reported on Form 4 filed with the SEC on May 26, 2026. Following the sale, Mazzara retains ownership of 103,343 shares. The filing indicates this w...

Gajendra Sanjay, President and COO of Astera Labs, filed a Form 4 reporting significant stock transactions. Between May 21-22, 2026, Sanjay sold a total of 400,000 shares of common stock through multiple transactions at weighted average prices ranging from $289.13 to $293.03 per share, generating approximately $116 mil...

Joao Kleber Dos Santos Cardoso, CFO and Corporate Secretary of Aura Minerals Inc., reported a transaction on May 25, 2026. He acquired 7,926 shares of Common Stock, bringing his total holdings to 154,917 shares. Additionally, he exercised stock options for 7,926 shares of Common Stock at a price of $17.35 per share, wi...

This SEC Form 4 filing reports securities lending transactions by Bruno Sousa Mauad, a director of Aura Minerals Inc. (ticker: AUGO). Between May 21-25, 2026, the filing discloses multiple securities lending agreements involving Brazilian Depository Receipts (BDRs) and underlying common shares. The transactions include...

Lara Caimi, a director at Aurora Innovation, Inc., reported a transaction involving 73,094 shares of Class A Common Stock on May 21, 2026. The transaction code "A" indicates acquisition, and the price per share was $0.00. These shares are represented by restricted stock units (RSUs), with specific vesting schedules out...

This filing details a Form 4 submission for Avalo Therapeutics, Inc. (AVTX) concerning a transaction on May 21, 2026. The transaction involved 100,200 shares of Common Stock, acquired under transaction code "A" with a price of $0.00 per share. Following this transaction, the post-transaction shares owned are 190,314. T...

VARKI PAUL, Chief Legal Officer of Avalo Therapeutics, Inc., acquired 24,300 shares of Common Stock on May 21, 2026. This acquisition is related to performance stock units (PSUs) granted on August 19, 2025, which vested on May 21, 2026, upon achievement of performance goals. The shares are subject to a vesting date of ...

Christopher Ryan Sullivan, Chief Financial Officer of Avalo Therapeutics, Inc., reported the vesting of 39,900 performance stock units (PSUs) on May 21, 2026. These PSUs, granted on August 19, 2025, represent a contingent right to receive one share of common stock per unit upon achievement of performance goals, which w...

This Form 4 filing reports that Doyle Mittie, Chief Medical Officer of Avalo Therapeutics, Inc., received 43,500 performance stock units (PSUs) on May 21, 2026. The PSUs were originally granted on August 19, 2025, and represent a contingent right to receive shares of common stock upon achievement of certain performance...

Jennifer Riley, Chief Strategy Officer of Avalo Therapeutics, Inc. (AVTX), reported a transaction involving 34,200 shares of Common Stock on May 21, 2026. These shares were acquired through performance stock units (PSUs) granted on August 19, 2025, with the achievement of performance goals certified on May 21, 2026. Th...

This Form 4 filing reports multiple distributions of Battalion Oil Corp (BATL) common stock by Luminus Energy Partners Master Fund, Ltd. to its investors. The distributions are part of an ongoing process following a March 24, 2026 distribution in kind of 5.2 million shares. Between April 9 and May 21, 2026, the Master ...

Diane D. Brink, a director at BELDEN INC. (BDC), acquired 1527 shares of common stock on May 21, 2026, as a grant under the company's 2021 Long Term Incentive Plan. The value of this grant was approximately $160,000, based on the closing price of $104.79 on the grant date. The restrictions on these shares are typically...

This filing details a transaction by Judy L. Brown, a director at Belden Inc., on May 21, 2026. Ms. Brown acquired 1527 shares of Common Stock under the company's 2021 Long Term Incentive Plan, as a grant valued at $160,000. The restrictions on these shares are expected to be lifted one year after the grant date, with ...

Nancy E. Calderon, a director at Belden Inc., acquired 1527 shares of Common Stock on May 21, 2026, with a reported transaction price of $0. This transaction is part of a grant of restricted stock under the company's 2021 Long Term Incentive Plan. The value of the grant was based on $160,000 divided by the closing pric...

This filing details a grant of restricted stock to director Jonathan C. Klein under the company's 2021 Long Term Incentive Plan. The grant, valued at $160,000, was based on the May 21, 2026 closing price of $104.79 per share, resulting in 1527 shares. Restrictions on these shares are generally lifted one year after the...

Vivie Lee, a director at Belden Inc. (BDC), acquired 1527 shares of Common Stock on May 21, 2026. This acquisition was a grant of restricted stock under the Company's 2021 Long Term Incentive Plan. The value of the grant was based on $160,000 divided by the closing price on the grant date, which was $104.79, resulting ...

Gregory James McCray, a director at BELDEN INC., acquired 1527 shares of Common Stock on May 21, 2026, with a transaction price of $0.0. This acquisition was made under the company's 2021 Long Term Incentive Plan, with the shares valued at $160,000. The restrictions on these shares are expected to be removed one year a...